HBIO - Harvard Bioscience, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue104,521108,664108,663
Cost of Revenue56,10659,94159,319
Gross Profit48,41548,72349,344
Operating Expenses
Research Development5,3926,4204,880
Selling General and Administrative42,62640,40935,051
Non Recurring6727881,027
Total Operating Expenses51,41250,43643,536
Operating Income or Loss-2,997-1,7136,618
Income from Continuing Operations
Total Other Income/Expenses Net561-1,041-401
Earnings Before Interest and Taxes-2,436-2,7545,407
Interest Expense642854990
Income Before Tax-3,078-3,6084,417
Income Tax Expense1,22915,4312,062
Minority Interest---
Net Income From Continuing Ops-4,307-19,0392,355
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-4,307-19,0392,355
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-4,307-19,0392,355